A: | HUMAN NECESSITIES | |
A61: | MEDICAL OR VETERINARY SCIENCE; HYGIENE | |
A61L: | METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES | |
A61L2/00: | Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor | |
A61L2/00P: | . for pharmaceuticals, biologicals or living parts | |
A61L2/00P2: | . . using physical methods | |
A61L2/00P2A: | . . . Filtration | |
A61L2/00P2E: | . . . Heat | |
A61L2/00P2F: | . . . Gamma radiation | |
A61L2/00P2R: | . . . Radiation | |
A61L2/00P2R10: | . . . . Infrared radiation | |
A61L2/00P2R12: | . . . . Microwaves | |
A61L2/00P2R14: | . . . . Particle radiation, e.g. electron-beam, alpha or beta radiation | |
A61L2/00P2R16: | . . . . using a photocatalyst or photosensitiser | |
A61L2/00P2R2: | . . . . Gamma radiation | |
A61L2/00P2R4: | . . . . X-rays | |
A61L2/00P2R6: | . . . . Ultraviolet radiation | |
A61L2/00P2R8: | . . . . Visible light | |
A61L2/00P4: | . . using chemical substances | |
A61L2/00P4A: | . . . Liquid substances | |
A61L2/00P4A2: | . . . . Peroxides | |
A61L2/00P4E: | . . . Gaseous substances | |
A61L2/02: | . using physical phenomena | |
A61L2/025: | . . Ultrasonics | |
A61L2/02F: | . . Filtration | |
A61L2/03: | . . Electric current | |
A61L2/03E: | . . . Electrolysis | |
A61L2/04: | . . Heat | |
A61L2/06: | . . . Hot gas | |
A61L2/07: | . . . . Steam | |
A61L2/08: | . . Radiation | |
A61L2/08B: | . . . Gamma radiation | |
A61L2/08D: | . . . X-rays | |
A61L2/08F: | . . . Visible light | |
A61L2/08H: | . . . Infrared radiation | |
A61L2/08J: | . . . Particle radiation, e.g. electron-beam, alpha or beta radiation | |
A61L2/08L: | . . . using a photocatalyst or photosensitiser | |
A61L2/10: | . . . Ultra-violet radiation | |
A61L2/12: | . . . Microwaves | |
A61L2/14: | . . Plasma, i.e. ionised gases | |
A61L2/16: | . using chemical substances | |
A61L2/18: | . . Liquid substances or solutions comprising solids or dissolved gases | |
A61L2/18L: | . . . Ozone dissolved in a liquid | |
A61L2/18P: | . . . Peroxide solutions | |
A61L2/20: | . . Gaseous substances, e.g. vapours | |
A61L2/20C: | . . . Ozone | |
A61L2/20D: | . . . Formaldehyde | |
A61L2/20E: | . . . Ethylene oxide | |
A61L2/20H: | . . . Hydrogen peroxide | |
A61L2/22: | . . Phase substances, e.g. smokes, aerosols or sprayed or atomised substances | |
A61L2/23: | . . Solid substances, e.g. granules, powders, blocks, tablets | |
A61L2/232: | . . . layered or coated | |
A61L2/235: | . . . cellular, porous or foamed | |
A61L2/238: | . . . Metals or alloys, e.g. oligodynamic metals | |
A61L2/24: | . Apparatus using programmed or automatic operation | |
A61L2/26: | . Accessories or devices or components used for biocidal treatment | |
A61L2/28: | . . Devices for testing the effectiveness or completeness of sterilisation, e.g. indicators which change colour | |
A61L9/00: | Disinfection, sterilisation or deodorisation of air | |
A61L9/01: | . Deodorant compositions compositions released by contact with a liquid A61L9/05 | |
A61L9/012: | . . characterised by being in a special form, e.g. gels, emulsions A61L9/04G takes precedence | |
A61L9/013: | . . containing animal or plant extracts, or vegetable material | |
A61L9/13: | . by air-liquid contact (e.g. scrubber) | |
A61L9/014: | . . containing sorbent material, e.g. activated carbon | |
A61L9/015: | . using gaseous or vaporous substances, e.g. ozone | |
A61L9/02: | . . using substances evaporated in the air by heating or combustion | |
A61L9/03: | . . . Apparatus therefor | |
A61L9/03F: | . . . . comprising a fan | |
A61L9/03M: | . . . . emanating multiple odours | |
A61L9/03W: | . . . . comprising a wick | |
A61L9/04: | . . using substances evaporated in the air without heating | |
A61L9/04B: | . . . with the help of a macromolecular compound as a carrier or diluent A61L9/04G takes precedence | |
A61L9/04C: | . . . with the help of an organic compound other than a macromolecular compound | |
A61L9/04D: | . . . with the help of a non-organic compound | |
A61L9/04G: | . . . air treating gels | |
A61L9/05: | . . . specially adapted to be released by contact with a liquid, e.g. for toilets | |
A61L9/12: | . . . Apparatus, e.g. holders, therefor | |
A61L9/12F: | . . . . comprising a fan | |
A61L9/12M: | . . . . emanating multiple odours | |
A61L9/12W: | . . . . comprising a wick | |
A61L9/14: | . using sprayed or atomised substances including air-liquid contact processes | |
A61L9/14L: | . . air-liquid contact processes, e.g. scrubbing | |
A61L9/16: | . using physical phenomena | |
A61L9/18: | . . Radiation | |
A61L9/20: | . . . Ultra-violet radiation | |
A61L9/20P: | . . . . using a photocatalyst or photosensitiser | |
A61L9/22: | . . Ionisation | |
A61L11/00: | Methods specially adapted for refuse desintegrating medical waste B02C19/12M; disposal of medical waste B09B3/00M | |
A61L12/00: | Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor | |
A61L12/02: | . using physical phenomena, e.g. electricity, ultrasonics or ultrafiltration | |
A61L12/02E: | . . Electrolysis | |
A61L12/02F: | . . Ultrasounds | |
A61L12/04: | . . Heat | |
A61L12/06: | . . Radiation, e.g. ultraviolet or microwaves | |
A61L12/06B: | . . . Ultraviolet radiation | |
A61L12/06D: | . . . Microwaves | |
A61L12/08: | . using chemical substances | |
A61L12/08B: | . . in combination with specific enzymes | |
A61L12/08D: | . . in a gaseous state | |
A61L12/08F: | . . Container, accessories or devices therefor | |
A61L12/08H: | . . Heavy metals | |
A61L12/10: | . . Halogens or compounds thereof | |
A61L12/10B: | . . . Chlorine dioxide (ClO2) | |
A61L12/10D: | . . . Iodine, iodides or iodophores | |
A61L12/10F: | . . . Hypohalites; Active halogens | |
A61L12/12: | . . Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone | |
A61L12/12B: | . . . Ozone | |
A61L12/12D: | . . . Hydrogen peroxide; Peroxy compounds | |
A61L12/12D2: | . . . . neutralised with catalase or peroxidase | |
A61L12/12D4: | . . . . neutralised with catalysts | |
A61L12/14: | . . Organic compounds not covered by groups A61L12/10 or A61L12/12 | |
A61L12/14B: | . . . Biguanides, e.g. chlorhexidine | |
A61L12/14B2: | . . . . Polymeric biguanides | |
A61L12/14D: | . . . Quaternary ammonium compounds | |
A61L12/14D2: | . . . . Polymeric quaternary ammonium compounds | |
A61L12/14F: | . . . Aldehydes | |
A61L12/14H: | . . . Alcohols or derivatives thereof aldehydes A61L12/14F | |
A61L12/14K: | . . . Mercury containing compounds, e.g. thimerosal | |
A61L15/00: | Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads | |
A61L15/07: | . Stiffening bandages | |
A61L15/08: | . . containing inorganic materials, e.g. plaster of Paris | |
A61L15/10: | . . containing organic materials | |
A61L15/12: | . . containing macromolecular materials | |
A61L15/12M: | . . . Mixtures of macromolecular compounds | |
A61L15/14: | . . Use of materials characterised by their function or physical properties | |
A61L15/16: | . Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons | |
A61L15/18: | . . containing inorganic materials | |
A61L15/20: | . . containing organic materials | |
A61L15/22: | . . containing macromolecular materials | |
A61L15/22M: | . . . Mixtures of macromolecular compounds | |
A61L15/24: | . . . Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof A61L15/22M takes precedence | |
A61L15/26: | . . . Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof A61L15/22M takes precedence | |
A61L15/28: | . . . Polysaccharides or their derivatives A61L15/22M takes precedence | |
A61L15/30: | . . . Rubbers or their derivatives A61L15/22M takes precedence | |
A61L15/32: | . . . Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin A61L15/22M takes precedence | |
A61L15/32A: | . . . . Collagen | |
A61L15/34: | . . . Oils, fats, waxes or natural resins A61L15/22M takes precedence | |
A61L15/36: | . . containing micro-organisms | |
A61L15/38: | . . containing enzymes | |
A61L15/40: | . . containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts | |
A61L15/42: | . . Use of materials characterised by their function or physical properties | |
A61L15/42E: | . . . Porous materials, e.g. foams or sponges | |
A61L15/44: | . . . Medicaments | |
A61L15/46: | . . . Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria | |
A61L15/48: | . . . Surfactants | |
A61L15/50: | . . . Lubricants; Anti-adhesive agents | |
A61L15/52: | . . . Water-repellants | |
A61L15/54: | . . . Radio-opaque materials | |
A61L15/56: | . . . Wetness-indicators or colourants | |
A61L15/58: | . . . Adhesives | |
A61L15/58M: | . . . . Mixtures of macromolecular compounds | |
A61L15/60: | . . . Liquid-swellable gel-forming materials, e.g. super-absorbents | |
A61L15/62: | . . . Compostable, hydrosoluble or hydrodegradable materials | |
A61L15/64: | . . . specially adapted to be resorbable inside the body | |
A61L17/00: | Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters bone cements or surgical adhesives for soft body tissues A61L24/00; shape or structure of prostheses A61F2/00; shape or structure of catheters A61M5/00 | |
A61L17/00C: | . containing a biologically active substance, e.g. a medicament or a biocide | |
A61L17/04: | . Non-resorbable materials | |
A61L17/06: | . At least partially resorbable materials | |
A61L17/08: | . . of animal origin, e.g. catgut, collagen | |
A61L17/10: | . . containing macromolecular materials | |
A61L17/10B: | . . . Polyesters not covered by A61L17/12 | |
A61L17/12: | . . . Homopolymers or copolymers of glycolic acid or lactic acid | |
A61L17/14: | . Post-treatment to improve physical properties | |
A61L17/14C: | . . Coating | |
A61L24/00: | Surgical adhesives or cements; Adhesives for colostomy devices | |
A61L24/00F: | . Ingredients of undetermined constitution or reaction products thereof | |
A61L24/00H: | . Use of materials characterised by their function or physical properties | |
A61L24/00H2: | . . Medicaments; Biocides | |
A61L24/00H4: | . . Plasticisers | |
A61L24/00H6: | . . Sprayable compositions | |
A61L24/00H7: | . . Hydrogels or hydrocolloids | |
A61L24/00H8: | . . Porous materials, e.g. foams or sponges | |
A61L24/00H9: | . . Materials resorbable by the body | |
A61L24/00R: | . Composite materials, i.e. containing one material dispersed in a matrix of the same or different material | |
A61L24/00R2: | . . with an inorganic matrix | |
A61L24/00R2A: | . . . Carbon | |
A61L24/00R2E: | . . . Phosphorus containing materials, e.g. apatite | |
A61L24/00R2K: | . . . Inorganic materials not covered by groups A61L24/00R2A or A61L24/00R2E | |
A61L24/00R4: | . . with a macromolecular matrix | |
A61L24/00R4A: | . . . containing fillers of carbon | |
A61L24/00R4E: | . . . containing fillers of phosphorus-containing inorganic compounds, e.g. apatite | |
A61L24/00R4K: | . . . containing inorganic fillers not covered by groups A61L24/00R4A or A61L24/00R4E | |
A61L24/00R4R: | . . . containing macromolecular fillers | |
A61L24/02: | . containing inorganic materials | |
A61L24/04: | . containing macromolecular materials | |
A61L24/04M: | . . Mixtures of macromolecular materials | |
A61L24/04R: | . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L24/04M takes precedence | |
A61L24/06: | . . obtained by reactions only involving carbon-to-carbon unsaturated bonds A61L24/04M, A61L24/04Rtake precedence | |
A61L24/08: | . . Polysaccharides A61L24/04M takes precedence | |
A61L24/10: | . . Polypeptides; Proteins A61L24/04M takes precedence | |
A61L24/10A: | . . . Collagen | |
A61L24/10E: | . . . Gelatin | |
A61L24/10F: | . . . Fibrin; Fibrinogen | |
A61L24/10R: | . . . Specific proteins or polypeptides not covered by groups A61L24/10A to A61L24/10F | |
A61L24/12: | . . Ionomer cements, e.g. glass-ionomer cements A61L24/04M takes precedence | |
A61L26/00: | Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form | |
A61L26/00A: | . containing inorganic materials | |
A61L26/00B: | . containing macromolecular materials | |
A61L26/00B2: | . . obtained by reactions only involving carbon-to-carbon unsaturated bonds | |
A61L26/00B4: | . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds | |
A61L26/00B5: | . . Polysaccharides | |
A61L26/00B6: | . . Polypeptides; Proteins; Degradation products thereof | |
A61L26/00B6A: | . . . Collagen | |
A61L26/00B6E: | . . . Gelatin | |
A61L26/00B6F: | . . . Fibrin; Fibrinogen | |
A61L26/00B6R: | . . . Specific proteins or polypeptides not covered by groups A61L26/00B6A to A61L26/00B6F | |
A61L26/00B8: | . . Mixtures of macromolecular compounds | |
A61L26/00F: | . Ingredients of undeterminded constitution or reaction products thereof | |
A61L26/00H: | . Use of materials characterised by their function or physical properties | |
A61L26/00H2: | . . Medicaments; Biocides | |
A61L26/00H4: | . . Plasticisers | |
A61L26/00H6: | . . Sprayable compositions | |
A61L26/00H7: | . . Hydrogels or hydrocolloids | |
A61L26/00H8: | . . Porous materials, e.g. foams or sponges | |
A61L26/00H9: | . . Materials resorbable by the body | |
A61L26/00R: | . Composite materials, i.e. containing one material dispersed in amatrix of the same or different material | |
A61L27/00: | Materials for grafts or prostheses or for coating grafts or prostheses | |
A61L27/02: | . Inorganic materials | |
A61L27/02B: | . . Other specific inorganic materials not covered by A61L27/04 to A61L27/12 | |
A61L27/04: | . . Metals or alloys | |
A61L27/04A: | . . . Iron or iron alloys | |
A61L27/04F: | . . . Cobalt or cobalt alloys | |
A61L27/04R: | . . . Other specific metals or alloys not covered by A61L27/04A to A61L27/04F or A61L27/06 | |
A61L27/06: | . . . Titanium or titanium alloys | |
A61L27/08: | . . Carbon; Graphite | |
A61L27/10: | . . Ceramics or glasses | |
A61L27/10A: | . . . containing Al2O3 | |
A61L27/12: | . . Phosphorus-containing materials, e.g. apatite | |
A61L27/14: | . Macromolecular materials | |
A61L27/16: | . . obtained by reactions only involving carbon-to-carbon unsaturated bonds | |
A61L27/16B: | . . . Rubbers | |
A61L27/18: | . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds | |
A61L27/20: | . . Polysaccharides | |
A61L27/22: | . . Polypeptides or derivatives thereof, e.g. degradation products | |
A61L27/22E: | . . . Gelatin | |
A61L27/22F: | . . . Fibrin; Fibrinogen | |
A61L27/22R: | . . . Other specific proteins or polypeptides not covered by A61L27/22E, A61L27/22F or A61L27/24 | |
A61L27/24: | . . . Collagen | |
A61L27/26: | . . Mixtures of macromolecular compounds | |
A61L27/28: | . Materials for coating prostheses | |
A61L27/30: | . . Inorganic materials | |
A61L27/30A: | . . . Carbon | |
A61L27/30R: | . . . Other specific inorganic materials not covered by A61L27/30A to A61L27/32 | |
A61L27/32: | . . . Phosphorus-containing materials, e.g. apatite | |
A61L27/34: | . . Macromolecular materials | |
A61L27/36: | . containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix isolated natural compounds, e.g. collagen A61L27/24 | |
A61L27/36B: | . . characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel | |
A61L27/36B10: | . . . Vascular tissue, e.g. heart valves | |
A61L27/36B12: | . . . Intestinal tissue, e.g. small intestinal submucosa | |
A61L27/36B14: | . . . Extracellular matrix (ECM) | |
A61L27/36B2: | . . . Bone, e.g. demineralised bone matrix [DBM , bone powder] | |
A61L27/36B4: | . . . Cartilage, synovial fluid | |
A61L27/36B6: | . . . Blood, e.g. platelet-rich plasma | |
A61L27/36B8: | . . . Skin, e.g. dermal papillae | |
A61L27/36D: | . . characterised by the origin of the biological material other than human or animal , e.g. plant extracts, algae | |
A61L27/36F: | . . characterised by the site of application in the body materials for artificial blood vessels A61L27/50E; materials for use in artificial skin A61L27/60 | |
A61L27/36F10: | . . . Hollow organs, e.g. bladder, esophagus, urether, uterus, intestine | |
A61L27/36F2: | . . . Connective tissue | |
A61L27/36F2B: | . . . . Bones | |
A61L27/36F2D: | . . . . Cartilage, e.g. meniscus | |
A61L27/36F2D2: | . . . . . Intervertebral discs mechanical aspects and structures of intervertebral discs A61F2/44D | |
A61L27/36F2F: | . . . . Ligaments, tendons | |
A61L27/36F4: | . . . Epithelial tissues other than skin | |
A61L27/36F6: | . . . Muscle tissue, e.g. sphincter | |
A61L27/36F8: | . . . Nerve tissue, e.g. brain, spinal cord, nerves, dura mater | |
A61L27/36H: | . . subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment | |
A61L27/36H2: | . . . characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents | |
A61L27/36H4: | . . . characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation | |
A61L27/36H6: | . . . characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this A61L27/36H2, A61L27/36H4 take precedence | |
A61L27/38: | . . containing added animal cells organs or tissue containing native cells A61L27/36 | |
A61L27/38B: | . . . characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells | |
A61L27/38B10: | . . . . Muscle cells, e.g. smooth muscle cells | |
A61L27/38B12: | . . . . Nerve cells, e.g. dendritic cells, Schwann cells | |
A61L27/38B14: | . . . . Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells | |
A61L27/38B2: | . . . . Endothelial cells | |
A61L27/38B4: | . . . . Epithelial cells, e.g. keratinocytes, urothelial cells | |
A61L27/38B6: | . . . . Cartilage-forming cells, e.g. pre-chondrocytes | |
A61L27/38B8: | . . . . Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells | |
A61L27/38D: | . . . characterised by the site of application in the body materials for artificial blood vessels A61L27/50E; materials for use in artificial skin A61L27/60 | |
A61L27/38D10: | . . . . Hollow organs, e.g. bladder, esophagus, urether, uterus | |
A61L27/38D2: | . . . . Connective tissue | |
A61L27/38D2B: | . . . . . Bones | |
A61L27/38D2D: | . . . . . Cartilage, e.g. meniscus | |
A61L27/38D2D2: | . . . . . . Intervertebral discs mechanical aspects and structures of intervertebral discs A61F2/44D | |
A61L27/38D2F: | . . . . . Ligaments, tendons | |
A61L27/38D2H: | . . . . . Dental/periodontal tissues | |
A61L27/38D4: | . . . . Epithelial tissues other than skin | |
A61L27/38D6: | . . . . Muscle tissue, e.g. sphincter | |
A61L27/38D8: | . . . . Nerve tissue, brain, spinal cord, nerves, dura mater | |
A61L27/38F: | . . . comprising two or more cell types | |
A61L27/38F2: | . . . . as distinct cell layers | |
A61L27/38H: | . . . using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions | |
A61L27/40: | . Composite materials, i.e. containing one material dispersed in a matrix of the same or different material | |
A61L27/42: | . . having an inorganic matrix | |
A61L27/42A: | . . . of carbon | |
A61L27/42E: | . . . of phosphorus containing material, e.g. apatite | |
A61L27/42R: | . . . of other specific inorganic materials not covered by A61L27/42A or A61L27/42E | |
A61L27/44: | . . having a macromolecular matrix | |
A61L27/44A: | . . . with carbon fillers | |
A61L27/44R: | . . . with other specific inorganic fillers other than those covered by A61L27/44A or A61L27/46 | |
A61L27/46: | . . . with phosphorus-containing inorganic fillers | |
A61L27/48: | . . . with macromolecular fillers | |
A61L27/50: | . Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials | |
A61L27/50B: | . . Plasticizers | |
A61L27/50D: | . . Stabilizers | |
A61L27/50E: | . . for artificial blood vessels apparatus for applying cells on a blood vessel prosthesis A61F2/06B | |
A61L27/52: | . . Hydrogels or hydrocolloids | |
A61L27/54: | . . Biologically active materials, e.g. therapeutic substances | |
A61L27/56: | . . Porous materials, e.g. foams or sponges | |
A61L27/58: | . . Materials at least partially resorbable by the body | |
A61L27/60: | . . Materials for use in artificial skin | |
A61L28/00: | Materials for colostomy devices | |
A61L28/00A: | . containing inorganic materials | |
A61L28/00B: | . containing macromolecular materials | |
A61L28/00B2: | . . obtained by reactions only involving carbon-to-carbon unsaturated bonds | |
A61L28/00B4: | . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds | |
A61L28/00B5: | . . Polysaccharides | |
A61L28/00B6: | . . Polypeptides; Proteins; Degradation products thereof | |
A61L28/00B8: | . . Mixtures of macromolecular compounds | |
A61L28/00F: | . Ingredients of undeterminded constitution or reaction products thereof | |
A61L28/00H: | . Use of materials characterised by their function or physical properties | |
A61L28/00H2: | . . Medicaments; Biocides | |
A61L28/00H4: | . . Plasticisers | |
A61L28/00H6: | . . Sprayable compositions | |
A61L28/00H7: | . . Hydrogels or hydrocolloids | |
A61L28/00H8: | . . Porous materials, e.g. foams or sponges | |
A61L28/00H9: | . . Materials resorbable by the body | |
A61L28/00K: | . Materials for coating | |
A61L28/00K2: | . . Inorganic materials | |
A61L28/00K4: | . . Macromolecular materials | |
A61L28/00R: | . Composite materials, i.e. containing one material dispersed in a matrix of the same or different material | |
A61L28/00R2: | . . with an inorganic matrix | |
A61L28/00R4: | . . with a macromolecular matrix | |
A61L28/00R4A: | . . . containing fillers of carbon | |
A61L28/00R4E: | . . . containing fillers of phosphorus-containing inorganic compounds | |
A61L28/00R4K: | . . . containing inorganic fillers not covered by groups A61L28/00R4A or A61L28/00R4E | |
A61L28/00R4R: | . . . containing macromolecular fillers | |
A61L29/00: | Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters | |
A61L29/00F: | . Ingredients of undetermined constitution or reaction products thereof | |
A61L29/02: | . Inorganic materials | |
A61L29/04: | . Macromolecular materials | |
A61L29/04B: | . . obtained by reactions only involving carbon-to-carbon unsaturated bonds | |
A61L29/04B2: | . . . Rubbers | |
A61L29/04D: | . . Polysaccharides | |
A61L29/04F: | . . Proteins; Polypeptides; Degradation products thereof | |
A61L29/04F10: | . . . Other specific proteins or polypeptides not covered by A61L29/04F2 to A61L29/04F6 | |
A61L29/04F2: | . . . Collagen | |
A61L29/04F4: | . . . Gelatin | |
A61L29/04F6: | . . . Fibrin; Fibrinogen | |
A61L29/04M: | . . Mixtures of macromolecular compounds | |
A61L29/06: | . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds | |
A61L29/08: | . Materials for coatings | |
A61L29/08B: | . . Macromolecular materials | |
A61L29/10: | . . Inorganic materials | |
A61L29/10A: | . . . Carbon | |
A61L29/10R: | . . . Inorganic materials other than carbon | |
A61L29/12: | . Composite materials, i.e. containig one material dispersed in a matrix of the same or different material | |
A61L29/12B: | . . having an inorganic matrix | |
A61L29/12D: | . . having a macromolecular matrix | |
A61L29/14: | . Materials characterised by their function or physical properties, e.g. lubricating compositions | |
A61L29/14B: | . . Plasticizers | |
A61L29/14D: | . . Stabilizers | |
A61L29/14F: | . . Hydrogels or hydrocolloids | |
A61L29/14H: | . . Porous materials, e.g. foams or sponges | |
A61L29/14K: | . . Materials at least partially resorbable by the body | |
A61L29/16: | . . Biologically active materials, e.g. therapeutic substances | |
A61L29/18: | . . Materials at least partially X-ray or laser opaque | |
A61L31/00: | Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices shape or structure of stent-grafts A61F2/07, of stents A61F2/82, of surgical gloves A61B19/04, of surgical drapes A61B19/08, of occluding devices A61B17/12P | |
A61L31/00F: | . Ingredients of undetermined constitution or reaction products thereof | |
A61L31/02: | . Inorganic materials | |
A61L31/02B: | . . Metals or alloys | |
A61L31/02D: | . . Carbon; Graphite | |
A61L31/02F: | . . Ceramic or ceramic-like structures, e.g. glasses | |
A61L31/02R: | . . Other inorganic materials not covered by A61L31/02B to A61L31/02F | |
A61L31/04: | . Macromolecular materials | |
A61L31/04B: | . . Mixtures of macromolecular compounds | |
A61L31/04D: | . . Polysaccharides | |
A61L31/04F: | . . Proteins; Polypeptides; Degradation products thereof | |
A61L31/04F10: | . . . Other specific proteins or polypeptides not covered by A61L31/04F2 to A61L31/04F6 | |
A61L31/04F2: | . . . Collagen | |
A61L31/04F4: | . . . Gelatin | |
A61L31/04F6: | . . . Fibrin; Fibrinogen | |
A61L31/04H: | . . obtained by reactions only involving carbon-to-carbon unsaturated bonds A61L31/04B takes precedence | |
A61L31/04H3: | . . . Rubbers | |
A61L31/06: | . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L31/04B takes precedence | |
A61L31/08: | . Materials for coatings | |
A61L31/08B: | . . Inorganic materials | |
A61L31/08B2: | . . . Carbon; Graphite | |
A61L31/08B4: | . . . Phosphorus-containing materials, e.g. apatite | |
A61L31/08B6: | . . . Other specific inorganic materials not covered by A61L31/08B2 or A61L31/08B4 | |
A61L31/10: | . . Macromolecular material | |
A61L31/12: | . Composite materials, i.e. containing one material dispersed in a matrix of the same or different material | |
A61L31/12B: | . . having an inorganic matrix | |
A61L31/12B2: | . . . of carbon | |
A61L31/12B4: | . . . of phosphorus-containing materials , e.g. apatite | |
A61L31/12B6: | . . . of other specific inorganic materials not coverd by A61L31/12B2 or A61L31/12B4 | |
A61L31/12D: | . . having a macromolecular matrix | |
A61L31/12D10: | . . . containing macromolecular fillers | |
A61L31/12D2: | . . . containing carbon fillers | |
A61L31/12D4: | . . . containing fillers of phosphorus-containing inorganic materials | |
A61L31/12D6: | . . . containing other specific inorganic fillers not covered by A61L31/12D2 or A61L31/12D4 | |
A61L31/14: | . Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials | |
A61L31/14B: | . . Plasticizers | |
A61L31/14D: | . . Stabilizers | |
A61L31/14F: | . . Hydrogels or hydrocolloids | |
A61L31/14H: | . . Porous materials, e.g. foams or sponges | |
A61L31/14K: | . . Materials at least partially resorbable by the body | |
A61L31/16: | . . Biologically active materials, e.g. therapeutic substances A61L31/04F10 takes precedence | |
A61L31/18: | . . Materials at least partially X-ray or laser opaque | |
A61L33/00: | Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment | |
A61L33/00H: | . Use of materials characterised by their function or physical properties | |
A61L33/00H2: | . . Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate | |
A61L33/00H2A: | . . . using a surface active agent | |
A61L33/00H2E: | . . . using a quaternized group or a protonated amine group of the substrate | |
A61L33/00H2F: | . . . using an intermediate layer of polymer | |
A61L33/00H2K: | . . . using a polymer with positively charged atoms in the polymeric backbone, e.g. ionenes | |
A61L33/00H2T: | . . . characterised by the choice of an antithrombatic agent other than heparin heparinoïd A61L33/08; polypeptides A61L33/12 | |
A61L33/00H3: | . . Enzymes, e.g. urokinase, streptokinase | |
A61L33/00H4: | . . Plasticizers | |
A61L33/00H5: | . . Stabilizers | |
A61L33/00H7: | . . Hydrogels or hydrocolloids | |
A61L33/00H8: | . . Porous materials, e.g. foams or sponges | |
A61L33/00R: | . Chemical modification of the substrate | |
A61L33/00R2: | . . by reacting with an organic compound other than heparin | |
A61L33/00R4: | . . by grafting of a monomer onto the substrate | |
A61L33/00T: | . Physical treatment, e.g. plasma treatment | |
A61L33/02: | . Use of inorganic materials | |
A61L33/02B: | . . Metal or alloys | |
A61L33/02D: | . . [N:Carbon; Graphite] | |
A61L33/02R: | . . Other specific inorganic materials not covered by A61L33/02B or A61L33/02D | |
A61L33/04: | . Use of organic materials, e.g. acetylsalicyclic acid | |
A61L33/06: | . Use of macromolecular materials | |
A61L33/06A: | . . Mixtures of macromolecular compounds | |
A61L33/06B: | . . obtained by reactions only involving carbon-to-carbon unsaturated bonds A61L33/06A takes precedence | |
A61L33/06B2: | . . . Rubbers | |
A61L33/06D: | . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L33/06A takes precedence | |
A61L33/08: | . . Polysaccharides | |
A61L33/12: | . . Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof | |
A61L33/12A: | . . . Collagen | |
A61L33/12E: | . . . Gelatin | |
A61L33/12F: | . . . Fibrin | |
A61L33/12R: | . . . Other specific proteins or polypeptides not covered by A61L33/12A to A61L33/12F | |
A61L33/18: | . Use of ingredients of undetermined constitution or reaction products thereof | |